Learning how well we are responding to a melanoma therapy or even predicting that response with a simple blood test would be sooooooooooooo AWESOME!!!! Researchers have been looking at various lab values in that regard. Here are some of the articles I've posted on the topic:
2015: Lab values that may predict response to Ipi/Yervoy????
2016: Biomarkers - blood components, circulating tumor cells AND of the tumor itself
Blood markers associated with clinical outcome of melanoma treated with ipi
2017: Eosinophilia - biomarker for prognosis in melanoma and importance in immunotherapy response
Now, there's this:
Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients. Failing, Yan, Porrata, Markovic. Melanoma Res. 2017 Oct 9.